- Home
- DBI vs INBX Comparison
DBI vs INBX Comparison
Compare DBI & INBX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DBI
- INBX
- Stock Information
- Founded
- DBI 1991
- INBX 2010
- Country
- DBI United States
- INBX United States
- Employees
- DBI N/A
- INBX N/A
- Industry
- DBI Clothing/Shoe/Accessory Stores
- INBX Biotechnology: Pharmaceutical Preparations
- Sector
- DBI Consumer Discretionary
- INBX Health Care
- Exchange
- DBI Nasdaq
- INBX Nasdaq
- Market Cap
- DBI 178.0M
- INBX 178.5M
- IPO Year
- DBI 1991
- INBX 2020
- Fundamental
- Price
- DBI $3.61
- INBX $13.53
- Analyst Decision
- DBI Hold
- INBX Hold
- Analyst Count
- DBI 2
- INBX 1
- Target Price
- DBI $4.75
- INBX N/A
- AVG Volume (30 Days)
- DBI 1.1M
- INBX 92.4K
- Earning Date
- DBI 06-10-2025
- INBX 05-14-2025
- Dividend Yield
- DBI 5.52%
- INBX N/A
- EPS Growth
- DBI N/A
- INBX N/A
- EPS
- DBI N/A
- INBX 111.58
- Revenue
- DBI $3,009,262,000.00
- INBX $200,000.00
- Revenue This Year
- DBI $2.22
- INBX N/A
- Revenue Next Year
- DBI $2.18
- INBX N/A
- P/E Ratio
- DBI N/A
- INBX $0.12
- Revenue Growth
- DBI N/A
- INBX N/A
- 52 Week Low
- DBI $2.44
- INBX $10.80
- 52 Week High
- DBI $11.06
- INBX $18.95
- Technical
- Relative Strength Index (RSI)
- DBI 56.01
- INBX 58.26
- Support Level
- DBI $3.10
- INBX $12.72
- Resistance Level
- DBI $3.82
- INBX $13.88
- Average True Range (ATR)
- DBI 0.23
- INBX 0.73
- MACD
- DBI 0.01
- INBX 0.14
- Stochastic Oscillator
- DBI 70.14
- INBX 88.20
About DBI Designer Brands Inc.
Designer Brands Inc is a designer, producer, and retailer of footwear and accessories. The company operates in three reportable segments: the U.S. Retail segment, the Canada Retail segment and the Brand Portfolio segment. The U.S. Retail segment operates the DSW Designer Shoe Warehouse banner through its direct-to-consumer U.S. stores and e-commerce site. The Canada Retail segment operates The Shoe Company and DSW banners through its direct-to-consumer Canada stores and e-commerce sites. The Brand Portfolio segment earns revenue from the sale of wholesale products to retailers, commissions for serving retailers as the design and buying agent for products under private labels, and the sale of branded products through its direct-to-consumer e-commerce sites.
About INBX Inhibrx Inc.
Inhibrx Biosciences Inc is a clinical-stage biopharmaceutical company with a pipeline of novel biologic therapeutic candidates, developed using its proprietary modular protein engineering platforms. Its clinical pipeline of therapeutic candidates includes INBRX-109 and INBRX-106, both of which utilize their multivalent formats where the precise valency can be optimized in a target-centric way to mediate what experts consider to be the predominant agonist function.